Retransplantation in 7,290 primary transplant patients: A 10-year multi-institutional study

Branislav Radovancevic, David C. McGiffin, Jon A. Kobashigawa, Guillermo B. Cintron, G. Martin Mullen, Douglas E. Pitts, Jacqueline O'Donnell, Cindi Thomas, Robert C. Bourge, David C. Naftel

Research output: Contribution to journalArticleResearchpeer-review

88 Citations (Scopus)


Background: Cardiac retransplantation is a controversial procedure due to the disparity between donor heart demand and supply. Methods: Of 7,290 patients undergoing primary cardiac transplantation between January 1990 and December 1999 at 42 institutions contributing to the Cardiac Transplant Research Database (CTRD), 106 patients later underwent a second and 1 patient a third cardiac transplant procedure. Results: The actuarial freedom from retransplantation was 99.2% and 96.8% at 1 and 10 years, respectively. Reasons for retransplantation included early graft failure (n = 34), acute cardiac rejection (n = 15), coronary allograft vasculopathy (CAV, n = 39), non-specific graft failure (n = 7), and miscellaneous (n = 10). The only risk factor associated with retransplantation was younger age, reflecting the policy of preferential retransplantation of younger patients. Survival after retransplantation was inferior to that after primary transplantation (56% and 38% at 1 and 5 years, respectively). Risk factors associated with death after retransplantation included retransplantation for acute rejection (p = 0.0005), retransplantation for early graft failure (p = 0.03), and use of a female donor (p = 0.005). Survival after retransplantation for acute rejection was poorest (32% and 8% at 1 and 5 years, respectively) followed by retransplantation for early graft failure (50% and 39% at 1 and 5 years, respectively). Survival after retransplantation for CAV has steadily improved with successive eras. Conclusions: The results of retransplantation for acute rejection and early graft failure are poor enough to suggest that this option is not advisable. However, retransplantation for CAV is currently associated with satisfactory survival and should continue to be offered to selected patients.

Original languageEnglish
Pages (from-to)862-868
Number of pages7
JournalThe Journal of Heart and Lung Transplantation
Issue number8
Publication statusPublished - 1 Aug 2003
Externally publishedYes

Cite this